Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
3.09
10.19
329.77%
Share Warrants & Outstandings
Total Reserve
204.71
276.52
-71.81
-25.97%
Shareholder's Funds
239.95
279.61
-39.66
-14.18%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
25.34
-25.34
-100.00%
Secured Loans
0.00
25.34
-25.34
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.07
2.23
0.84
37.67%
Other Long Term Liabilities
8.30
0.17
8.13
4,782.35%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
3.81
-2.77
-72.70%
Total Non-Current Liabilities
12.41
31.54
-19.13
-60.65%
Current Liabilities
Trade Payables
9.73
54.16
-44.43
-82.03%
Other Current Liabilities
15.16
12.15
3.01
24.77%
Short Term Borrowings
0.00
46.84
-46.84
-100.00%
Short Term Provisions
1.01
1.44
-0.43
-29.86%
Total Current Liabilities
25.90
114.61
-88.71
-77.40%
Total Liabilities
278.26
425.76
-147.50
-34.64%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
176.87
-83.40
-47.15%
Less: Accumulated Depreciation
7.25
56.98
-49.73
-87.28%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
119.89
-33.66
-28.08%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
49.73
-49.73
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
3.73
-3.73
-100.00%
Long Term Loans & Advances
1.33
21.43
-20.10
-93.79%
Other Non Current Assets
21.29
1.12
20.17
1,800.89%
Total Non-Current Assets
117.07
195.89
-78.82
-40.24%
Current Assets Loans & Advances
Current Investments
0.00
59.66
-59.66
-100.00%
Inventories
15.20
49.07
-33.87
-69.02%
Sundry Debtors
13.18
79.77
-66.59
-83.48%
Cash and Bank
128.73
5.73
123.00
2,146.60%
Other Current Assets
1.66
3.41
-1.75
-51.32%
Short Term Loans and Advances
2.42
32.22
-29.80
-92.49%
Total Current Assets
161.19
229.87
-68.68
-29.88%
Net Current Assets (Including Current Investments)
135.29
115.27
20.02
17.37%
Total Current Assets Excluding Current Investments
161.19
170.21
-9.02
-5.30%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
425.76
-147.50
-34.64%
Contingent Liabilities
16.17
0.42
15.75
3,750.00%
Total Debt
0.00
72.18
-72.18
-100.00%
Book Value per share (adjusted)
36.08
452.60
-416.52
-92.03%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024






